Independent Financial Group LLC Takes Position in Stryker Corporation $SYK

Independent Financial Group LLC acquired a new position in Stryker Corporation (NYSE:SYK) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 2,229 shares of the medical technology company’s stock, valued at approximately $732,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sankala Group LLC purchased a new stake in shares of Stryker during the fourth quarter valued at $26,000. United Financial Planning Group LLC acquired a new position in shares of Stryker in the third quarter worth about $27,000. Godfrey Financial Associates Inc. purchased a new position in shares of Stryker in the fourth quarter worth approximately $26,000. Atlas Capital Advisors Inc. acquired a new stake in shares of Stryker during the fourth quarter valued at approximately $27,000. Finally, Strive Asset Management LLC acquired a new stake in shares of Stryker during the third quarter valued at approximately $30,000. 77.09% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, VP M Kathryn Fink sold 5,220 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the sale, the vice president directly owned 13,137 shares of the company’s stock, valued at $3,728,937.45. This trade represents a 28.44% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the sale, the director owned 1,924,880 shares of the company’s stock, valued at approximately $601,005,282.40. This represents a 13.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 323,264 shares of company stock valued at $100,659,489 in the last three months. Insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on SYK. JPMorgan Chase & Co. lowered their price objective on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Sanford C. Bernstein set a $410.00 target price on Stryker in a report on Friday, May 1st. Robert W. Baird set a $385.00 price target on Stryker in a report on Friday, May 1st. Barclays dropped their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. Finally, Needham & Company LLC decreased their price objective on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and a consensus target price of $392.52.

Stryker Stock Down 1.6%

SYK stock opened at $313.89 on Wednesday. The company has a 50 day moving average of $313.79 and a two-hundred day moving average of $336.20. The company has a market cap of $120.33 billion, a price-to-earnings ratio of 36.33, a PEG ratio of 2.04 and a beta of 0.77. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. During the same quarter in the prior year, the firm earned $2.84 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities analysts anticipate that Stryker Corporation will post 14.99 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.